Prospects for immunotherapy of MHC class I-deficient tumours
1.
SYSNO ASEP
0191552
Document Type
J - Journal Article
R&D Document Type
Journal Article
Subsidiary J
Ostatní články
Title
Prospects for immunotherapy of MHC class I-deficient tumours
Author(s)
Bubeník, Jan (UMG-J)
Source Title
Folia Biologica. - : Univerzita Karlova v Praze
- ISSN 0015-5500
Roč. 49, č. 3 (2003), s. 95-99
Number of pages
5 s.
Language
eng - English
Country
CZ - Czech Republic
Keywords
MHC class I ; immunotherapy
Subject RIV
FD - Oncology ; Hematology
CEZ
AV0Z5052915 - UMG-J
Annotation
More attention should be paid to the MHC class I status of the neoplasms during the elaboration of tumour immunotherapy protocols with regard to the possible cytokine therapy. Prospectively, the therapeutic role of the induction of MHC class I expression by demethylation and acetylation agents prior to or simultaneously with the immunotherapy should also be investigated.
